Literature DB >> 21499722

Rhabdomyolysis induced by severe levodopa induced dyskinesia in a patient with Parkinson's disease.

Chul Hyoung Lyoo, Myung Sik Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21499722     DOI： 10.1007/s00415-011-6041-x

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Dyskinesia-hyperpyrexia syndrome: another Parkinson's disease emergency.

Authors:  Silvia Gil-Navarro; Francisco Grandas
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  Spinal myoclonus following intrathecal administration of diatrizoate meglumine.

Authors:  M C Sam; L Gutmann
Journal:  J Neuroimaging       Date:  1996-10       Impact factor: 2.486

Review 3.  Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.

Authors:  Jan Claassen; Lawrence J Hirsch; Ronald G Emerson; Stephan A Mayer
Journal:  Epilepsia       Date:  2002-02       Impact factor: 5.864

4.  Myoglobinuric renal failure in Huntington's chorea.

Authors:  J Jankovic
Journal:  Neurology       Date:  1986-01       Impact factor: 9.910

5.  Status dystonicus: the syndrome and its management.

Authors:  H Manji; R S Howard; D H Miller; N P Hirsch; L Carr; K Bhatia; N Quinn; C D Marsden; K Bahtia
Journal:  Brain       Date:  1998-02       Impact factor: 13.501

Review 6.  Movement disorder emergencies.

Authors:  Christopher M Kipps; Victor S C Fung; Padraic Grattan-Smith; Gregory M de Moore; John G L Morris
Journal:  Mov Disord       Date:  2005-03       Impact factor: 10.338

Review 7.  Emergency department presentations of patients with Parkinson's disease.

Authors:  S A Factor; E S Molho
Journal:  Am J Emerg Med       Date:  2000-03       Impact factor: 2.469

8.  A collaborative study on the malignant syndrome in Parkinson's disease and related disorders.

Authors:  Hideki Takubo; Toshihide Harada; Takao Hashimoto; Yutaka Inaba; Ichiro Kanazawa; Sadako Kuno; Yoshikuni Mizuno; Eiji Mizuta; Miho Murata; Toshiharu Nagatsu; Shigenobu Nakamura; Nobuo Yanagisawa; Hirotaro Narabayashi
Journal:  Parkinsonism Relat Disord       Date:  2003-04       Impact factor: 4.891
  8 in total
  7 in total

Review 1.  Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.

Authors:  Tai N Tran; Trang N N Vo; Karen Frei; Daniel D Truong
Journal:  J Neural Transm (Vienna)       Date:  2018-07-03       Impact factor: 3.575

2.  A substrate pharmacophore for the human organic cation/carnitine transporter identifies compounds associated with rhabdomyolysis.

Authors:  Sean Ekins; Lei Diao; James E Polli
Journal:  Mol Pharm       Date:  2012-02-28       Impact factor: 4.939

3.  Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease.

Authors:  Anna Delamarre; François Tison; Qin Li; Monique Galitzky; Olivier Rascol; Erwan Bezard; Wassilios G Meissner
Journal:  J Neural Transm (Vienna)       Date:  2019-05-16       Impact factor: 3.575

Review 4.  Dyskinesia-hyperpyrexia syndrome in Parkinson's disease: a systematic review.

Authors:  Miao Wang; Wei Wang; Zhongbao Gao; Xi Yin; Tong Chen; Ziying Jiang; Zhenfu Wang
Journal:  Clin Auton Res       Date:  2021-04-07       Impact factor: 4.435

5.  Rhabdomyolysis related to dyskinesia in Parkinson's disease.

Authors:  Hesna Bektaş; Orhan Deniz; Sadiye Temel; Hava Dönmez Keklikoğlu; Sener Akyol
Journal:  J Mov Disord       Date:  2014-04-30

Review 6.  Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson's Disease.

Authors:  Nicole Elaine Chambers; Kathryn Lanza; Christopher Bishop
Journal:  Front Pharmacol       Date:  2020-01-15       Impact factor: 5.810

Review 7.  Rhabdomyolysis Associated with Severe Levodopa-Induced Dyskinesia in Parkinson's Disease: A Report of Two Cases and Literature Review.

Authors:  Yuvadee Pitakpatapee; Jindapa Srikajon; Tanita Sangpeamsook; Prachaya Srivanitchapoom
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2021-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.